Feature | TCGA (N = 66) | Our samples (N = 60) |
---|---|---|
Age (yrs) | 50 (42–60) | 50 (40–62) |
Gender, n (%) | ||
 Male | 39 (60) | 23 (38) |
 Female | 26 (40) | 37 (62) |
Pathologic_stage, n (%) | ||
 I | 20 (31) | 22 (37) |
 II | 25 (39) | 22 (37) |
 III | 16 (25) | 13 (22) |
 IV | 4 (6) | 3 (5) |
Pathologic_T, n (%) | ||
 pT1 | 20 (31) | 22 (37) |
 pT2 | 25 (39) | 22 (37) |
 pT3 | 18 (28) | 14 (23) |
 pT4 | 2 (3) | 2 (3) |
Pathologic_N, n (%) | ||
 pN0 | 39 (60) | 58 (97) |
 pN1 | 5 (8) | 2 (3) |
 Unknown | 21 (32) | 0 (0) |
Pathologic_M, n (%) | ||
 M0 | 34 (52) | 58 (97) |
 M1 | 2 (3) | 2 (3) |
 Unknown | 29 (45) | 0 (0) |
Presence_of_sarcomatoid_features, n (%) | ||
 No | 62 (95) | 58 (97) |
 Yes | 3 (5) | 2 (3) |
 Unknown | 49 (43) | 0 (0) |